Danielle Campbell
Personalreferent bei ATYR PHARMA, INC.
Aktive Positionen von Danielle Campbell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATYR PHARMA, INC. | Personalreferent | 24.12.2021 | - |
Karriereverlauf von Danielle Campbell
Ehemalige bekannte Positionen von Danielle Campbell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Personalreferent | 01.01.2016 | 01.01.2019 |
| Corporate Officer/Principal | 01.01.2019 | 01.01.2021 | |
| ATYR PHARMA, INC. | Personalreferent | 01.11.2015 | 01.06.2016 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Personalreferent | 01.09.2014 | 01.11.2015 |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Personalreferent | 01.04.2008 | 01.09.2014 |
Ausbildung von Danielle Campbell
| University of California, Irvine | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Human Resources Officer | 5 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Danielle Campbell
- Erfahrung
